Business Description
Comera Life Sciences Holdings Inc
NAICS : 541714
SIC : 2836
ISIN : US20037C1080
Description
Comera Life Sciences Holdings Inc is a pre-clinical biotechnology company dedicated to promoting formulation science and technology to transform essential biologic medicines from intravenous to subcutaneous forms. Comera's internal portfolio of proprietary techniques known as the SQore platform is designed to potentially transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, and optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. It also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to the Company's partners' biologic medicines to deliver enhanced formulations that facilitate self-injectable care.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.28 | |||||
| Equity-to-Asset | -1.37 | |||||
| Debt-to-Equity | -0.04 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -28 | |||||
| Beneish M-Score | -6.21 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.2 | |||||
| 9-Day RSI | 48.43 | |||||
| 14-Day RSI | 49.01 | |||||
| 6-1 Month Momentum % | -89.7 | |||||
| 12-1 Month Momentum % | -95.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | |||||
| Quick Ratio | 0.9 | |||||
| Cash Ratio | 0.6 | |||||
| Days Sales Outstanding | 61.87 | |||||
| Days Payable | 2193.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 5.77 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.5 | |||||
| Operating Margin % | -914.6 | |||||
| Net Margin % | -901 | |||||
| FCF Margin % | -675.6 | |||||
| ROA % | -263.84 | |||||
| ROIC % | -383.38 | |||||
| ROC (Joel Greenblatt) % | -1875.78 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.7 | |||||
| EV-to-EBIT | 0.04 | |||||
| EV-to-EBITDA | 0.04 | |||||
| EV-to-Revenue | -0.34 | |||||
| EV-to-FCF | 0.05 | |||||
| Earnings Yield (Greenblatt) % | 2500 | |||||
| FCF Yield % | -609.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CMRA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Comera Life Sciences Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1 | ||
| EPS (TTM) ($) | -0.492 | ||
| Beta | 0 | ||
| Volatility % | 85.84 | ||
| 14-Day RSI | 49.01 | ||
| 14-Day ATR ($) | 0.004709 | ||
| 20-Day SMA ($) | 0.040035 | ||
| 12-1 Month Momentum % | -95.7 | ||
| 52-Week Range ($) | 0.0215 - 0.8255 | ||
| Shares Outstanding (Mil) | 30.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Comera Life Sciences Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Comera Life Sciences Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Comera Life Sciences Holdings Inc Frequently Asked Questions
What is Comera Life Sciences Holdings Inc(CMRA)'s stock price today?
The current price of CMRA is $0.04. The 52 week high of CMRA is $0.83 and 52 week low is $0.02.
When is next earnings date of Comera Life Sciences Holdings Inc(CMRA)?
The next earnings date of Comera Life Sciences Holdings Inc(CMRA) is 2024-05-31 Est..
Does Comera Life Sciences Holdings Inc(CMRA) pay dividends? If so, how much?
Comera Life Sciences Holdings Inc(CMRA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers